Evolution of surgical treatment for breast cancer
- Authors: Kcheuso A.V.1, Shapovalov S.G.1,2, Savchenkov D.K.3, Koshelev T.E.3, Votinova A.O.3
-
Affiliations:
- Nikiforov’s All-Russian Center for Emergency and Radiation Medicine
- Pavlov First Saint Petersburg State Medical University
- North-Western State Medical University named after I.I. Mechnikov
- Issue: Vol 14, No 2 (2022)
- Pages: 49-58
- Section: Reviews
- URL: https://journals.eco-vector.com/vszgmu/article/view/81010
- DOI: https://doi.org/10.17816/mechnikov81010
Cite item
Abstract
Breast cancer holds the leading position among women’s cancer. Nowadays extensive experience has been acquired in surgical treatment of this disease. However, a significant proportion of young and middle-aged patients, the expansion of adjuvant therapy capabilities and the effectiveness of integrated treatment dictate a need to pay more attention to the aestheticity of surgical interventions. The review analyzes the results of the modern studies on the effectiveness and aestheticity of the most common types of surgical treatment of breast cancer; the evolutionary trends in oncosurgery are presented.
Full Text

About the authors
Aleksandr V. Kcheuso
Nikiforov’s All-Russian Center for Emergency and Radiation Medicine
Email: kcheuso@mail.ru
ORCID iD: 0000-0002-5889-3564
SPIN-code: 4247-6662
Russian Federation, Saint Petersburg
Sergey G. Shapovalov
Nikiforov’s All-Russian Center for Emergency and Radiation Medicine; Pavlov First Saint Petersburg State Medical University
Email: shapovalov_serg@mail.ru
ORCID iD: 0000-0002-5630-5247
SPIN-code: 7709-3186
MD, Dr. Sci. (Med.), Professor
Russian Federation, Saint Petersburg; Saint PetersburgDmitry K. Savchenkov
North-Western State Medical University named after I.I. Mechnikov
Email: savchenkov.dmitrij@gmail.com
ORCID iD: 0000-0003-4626-1639
SPIN-code: 4411-3009
MD, Cand. Sci. (Med.)
Russian Federation, Saint PetersburgTaras E. Koshelev
North-Western State Medical University named after I.I. Mechnikov
Email: kte@yandex.ru
ORCID iD: 0000-0002-6399-6963
SPIN-code: 8939-7732
MD, Cand. Sci. (Med.), Assistant Professor
Russian Federation, Saint PetersburgAnastasia O. Votinova
North-Western State Medical University named after I.I. Mechnikov
Author for correspondence.
Email: Votinova.anastasya@gmail.com
Russian Federation, Saint Petersburg
References
- Zlokachestvennye novoobrazovaniya v Rossii v 2015 godu (zabolevaemost’ i smertnost’). Ed. by A.D. Kaprin, V.V. Starinskii, G.V. Petrova. Moscow; 2017. (In Russ.)
- Merabishvili VM. Malignant tumorsin the North-West Federal Region of Russia (morbidity, mortality, prevalence rate, survival). Ed. by A.M. Belyaev. Saint Petersburg; 2017.
- Global Cancer Facts and Figures 2016. Atlanta: American Cancer Society; 2016.
- Stenina MB, Frolova MA. Rak molochnoi zhelezy: naibolee vazhnye nauchnye sobytiya i vyvody poslednikh let. Practical Oncology. 2011;12(1):6–11. (In Russ.)
- Sostoyanie onkologicheskoi pomoshchi naseleniyu Rossii v 2016 godu. Ed. by A.D. Kaprin, V.V. Starinskii, G.V. Petrova. Moscow; 2017. (In Russ.)
- Abduraimov AB, Ternovoy SK. New possibilities of radiologic diagnostics of breast cancer. Tumors of female reproductive system. 2008;(3):24–28. (In Russ.). doi: 10.17650/1994-4098-2008-0-3-24-28
- Ilkevich AG. Mammografiya v kompleksnoi diagnostike raka molochnoi zhelezy. News of Beam Diagnostics Belarus. 2001;1–2:29–31. (In Russ.)
- Semiglazov VV, Semiglazov VF, Ermachenkova AM. Minimal’nye formy raka molochnoi zhelezy. Problems in Oncology. 2011;57(6):702–706. (In Russ.)
- Breasted JH. The Edwin Smith surgical papyrus. Classics of Medicine Library. Chicago: University of Chicago Press; 1930.
- Izuo M. Medical history: Seishu Hanaoka and his success in breast cancer surgery under general anesthesia two hundred years ago. Breast Cancer. 2004;11(4):319–324. doi: 10.1007/BF02968037
- Dote K, Ikemune K, Desaki Y, et al. Two Japanese pioneers in anesthesiology: Seishū Hanaoka and Gendai Kamada. J Anesth Hist. 2017;3(1):19–23. doi: 10.1016/j.janh.2016.12.002
- Freeman MD, Gopman JM, Salzberg CA. The evolution of mastectomy surgical technique: from mutilation to medicine. Gland Surg. 2018;7(3):308–315. doi: 10.21037/gs.2017.09.07
- Halsted WS. The results of operations for the cure of cancer of the breast performed at the Johns Hopkins Hospital from June, 1889, to January, 1894. Ann Surg. 1894;20(5):497–555. doi: 10.1097/00000658-189407000-00075
- Halsted WS. A clinical and histological study of certain adenocarcinomata of the breast: and a brief consideration of the supraclavicular operation and of the Results of Operations for Cancer of the Breast from 1889 to 1898 at the Johns Hopkins Hospital. Ann Surg. 1898;28(5):557–576.
- Halsted WS. The results of radical operations for the cure of carcinoma of the breast. Ann Surg. 1907;46(1):1–19. doi: 10.1097/00000658-190707000-00001
- Meyer W. An improved method of the radical operation for carcinoma of the breast. New York: Trow Directory, Printing and Bookbinding Co.; 1894.
- Kushtalov NI. O vliyanii Kh-luchei na molochnuyu zhelezu krolikov i sobak [dissertation]. Saint Petersburg; 1910. (In Russ.)
- Patey DH, Dyson WH. The prognosis of carcinoma of the breast in relation to the type of operation performed. Br J Cancer. 1948;2(1):7–13. doi: 10.1038/bjc.1948.2
- Freeman BS. Subcutaneous mastectomy for benign breast lesions with immediate or delayed prosthetic replacement. Plast Reconstr Surg Transplant Bull. 1962;30:676–682. doi: 10.1097/00006534-196212000-00008
- Toth BA, Lappert P. Modified skin incisions for mastectomy: the need for plastic surgical input in preoperative planning. Plast Reconstr Surg. 1991;87(6):1048–1053.
- Torresan RZ, dos Santos CC, Okamura H, Alvarenga M. Evaluation of residual glandular tissue after skin-sparing mastectomies. Ann Surg Oncol. 2005;12(12):1037–1044. doi: 10.1245/ASO.2005.11.027
- Barton FE Jr, English JM, Kingsley WB, Fietz M. Glandular excision in total glandular mastectomy and modified radical mastectomy: a comparison. Plast Reconstr Surg. 1991;88(3):389–392. doi: 10.1097/00006534-199109000-00001
- Carlson GW, Styblo TM, Lyles RH, et al. Local recurrence after skin-sparing mastectomy: tumor biology or surgical conservatism? Ann Surg Oncol. 2003;10(2):108–112. doi: 10.1245/aso.2003.03.053
- Ho CM, Mak CK, Lau Y, et al. Skin involvement in invasive breast carcinoma: safety of skin-sparing mastectomy. Ann Surg Oncol. 2003;10(2):102–107. doi: 10.1245/aso.2003.05.001
- Romics L Jr, Chew BK, Weiler-Mithoff E, et al. Ten-year follow-up of skin-sparing mastectomy followed by immediate breast reconstruction. Br J Surg. 2012;99(6):799–806. doi: 10.1002/bjs.8704
- Lowery AJ, Kell MR, Glynn RW, et al. Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype. Breast Cancer Res Treat. 2012;133(3):831–841. doi: 10.1007/s10549-011-1891-6
- Lanitis S, Tekkis PP, Sgourakis G, et al. Comparison of skin-sparing mastectomy versus non-skin-sparing mastectomy for breast cancer: a meta-analysis of observational studies. Ann Surg. 2010;251(4):632–639. doi: 10.1097/SLA.0b013e3181d35bf8
- Yi M, Kronowitz SJ, Meric-Bernstam F, et al. Local, regional, and systemic recurrence rates in patients undergoing skin-sparing mastectomy compared with conventional mastectomy. Cancer. 2011;117(5):916–924. doi: 10.1002/cncr.25505
- Mota BS, Riera R, Ricci MD, et al. Nipple- and areola-sparing mastectomy for the treatment of breast cancer. Cochrane Database Syst Rev. 2016;11(11):CD008932. doi: 10.1002/14651858.CD008932.pub3
- Weber WP, Haug M, Kurzeder C, et al. Oncoplastic Breast Consortium consensus conference on nipple-sparing mastectomy. Breast Cancer Res Treat. 2018;172(3):523–537. doi: 10.1007/s10549-018-4937-1
- NIH consensus conference. Treatment of early-stage breast cancer. JAMA. 1991;265(3):391–395.
- Clinical practice guidelines for the managment of early breast cancer. 2nd ed. Canberra: ACT: National Health and Medical Research Council; 2001.
- Senkus E, Kyriakides S, Ohno S, et al. Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26 Suppl 5:v8–v30. doi: 10.1093/annonc/mdv298
- Pyfer B, Chatterjee A, Chen L, et al. Early postoperative outcomes in breast conservation surgery versus simple mastectomy with implant reconstruction: a NSQIP analysis of 11,645 patients. Ann Surg Oncol. 2016;23(1):92–98. doi: 10.1245/s10434-015-4770-2
- Litière S, Werutsky G, Fentiman IS, et al. Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial. Lancet Oncol. 2012;13(4):412–419. doi: 10.1016/S1470-2045(12)70042-6
- Roder D, Zorbas H, Kollias J, et al. Factors predictive of treatment by Australian breast surgeons of invasive female breast cancer by mastectomy rather than breast conserving surgery. Asian Pac J Cancer Prev. 2013;14(1):539–545. doi: 10.7314/apjcp.2013.14.1.539
- Baade PD, Dasgupta P, Youl PH, et al. Geographical inequalities in surgical treatment for localized female breast cancer, Queensland, Australia 1997-2011: improvements over time but inequalities remain. Int J Environ Res Public Health. 2016;13(7):729. doi: 10.3390/ijerph13070729
- Spilsbury K, Semmens JB, Saunders CM, et al. Subsequent surgery after initial breast conserving surgery: a population based study. ANZ J Surg. 2005;75(5):260–264. doi: 10.1111/j.1445-2197.2005.03352.x
- Isaacs AJ, Gemignani ML, Pusic A, Sedrakyan A. Association of breast conservation surgery for cancer with 90-day reoperation rates in New York State. JAMA Surg. 2016;151(7):648–655. doi: 10.1001/jamasurg.2015.5535
- van Leeuwen MT, Falster MO, Vajdic CM, et al. Reoperation after breast-conserving surgery for cancer in Australia: statewide cohort study of linked hospital data. BMJ Open. 2018;8(4):e020858. doi: 10.1136/bmjopen-2017-020858
- Zhang X, Wang Y. A survey of current surgical treatment of early stage breast cancer in China. Oncoscience. 2018;5(7–8):239–247. doi: 10.18632/oncoscience.445
- Habermann EB, Abbott A, Parsons HM, et al. Are mastectomy rates really increasing in the United States? J Clin Oncol. 2010;28(21):3437–3441. doi: 10.1200/JCO.2009.27.6774
- Morrow M, Jagsi R, Alderman AK, et al. Surgeon recommendations and receipt of mastectomy for treatment of breast cancer. JAMA. 2009;302(14):1551–1556. doi: 10.1001/jama.2009.1450
- Tuttle TM, Rueth NM, Abbott A, Virnig BA. United States trends in the surgical treatment of primary breast cancer. World J Surg. 2012;36(7):1475–1479. doi: 10.1007/s00268-012-1469-4
- McCahill LE, Single RM, Aiello Bowles EJ, et al. Variability in reexcision following breast conservation surgery. JAMA. 2012;307(5):467–475. doi: 10.1001/jama.2012.43
- Albornoz CR, Cemal Y, Mehrara BJ. The impact of bilateral mastectomy on reconstructive rate and method in the United States: a population based analysis. Plast Reconstr Surg. 2012;130(5S–1):77. doi: 10.1097/01.prs.0000421791.76960.1f
- Feigelson HS, James TA, Single RM, et al. Factors associated with the frequency of initial total mastectomy: results of a multi-institutional study. J Am Coll Surg. 2013;216(5):966–975. doi: 10.1016/j.jamcollsurg.2013.01.011
- Del Turco MR, Ponti A, Bick U, et al. Quality indicators in breast cancer care. Eur J Cancer. 2010;46(13):2344–2356. doi: 10.1016/j.ejca.2010.06.119
- Silverstein MJ, Recht A, Lagios MD, et al. Special report: Consensus conference III. Image- detected breast cancer: state-of-the-art diagnosis and treatment. J Am Coll Surg. 2009;209(4):504–520. doi: 10.1016/j.jamcollsurg.2009.07.006
- Kaufman CS, Landercasper J. Can we measure the quality of breast surgical care? Ann Surg Oncol. 2011;18(11):3053–3060. doi: 10.1245/s10434-011-1998-3
- Parvez E, Hodgson N, Cornacchi SD, et al. Survey of American and Canadian general surgeons’ perceptions of margin status and practice patterns for breast conserving surgery. Breast J. 2014;20(5):481–488. doi: 10.1111/tbj.12299
- Blitz A. Where is the outrage? Isr Med Assoc J. 2010;12(2):127.
- Krag DN, Anderson SJ, Julian TB, et al. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol. 2007;8(10):881–888. doi: 10.1016/S1470-2045(07)70278-4
Supplementary files
There are no supplementary files to display.
